Advertisement

Topics

Latest Bioinformatics NewsRSS

15:53 EDT 19th October 2017 | BioPortfolio

ComputerAssisted Coding Global Market Outlook 20172023 [Report Updated: 01092017] Prices from USD $4150

According to Stratistics MRC, The Global ComputerAssisted Coding Market is accounted for $2.47 billion in 2016 and expected to grow at a CAGR of 13.4% to reach $5.98 billion by 2023. The market factors such as increasing utilization of CAC solutions to curtail the rising healthcare costs, growing focus on physician computerassisted coding in outpatient settings, increasing implementation of Ehr Sy...

US Regulators Approve 2nd Gene Therapy For Blood Cancer

NewsThe treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker Gilead Sciences. Contributed Author: 

uniQure Strengthens Intellectual Property Portfolio with Acquisition of Patent Family Providing Broad Protection of the Hyperactive Padua Variant of Factor IX (FIX-Padua)

~ Issued Patent in the U.S. Covers Use of FIX-Padua in Gene Therapy ~ ~ Divisional patent applications filed to further strengthen Padua intellectual property position ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 19, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today...

uniQure Announces Hemophilia B Gene Therapy Program To Enter Pivotal Study With FIX-Padua Variant in 2018

~ AMT-060 with the FIX-Padua Modification (AMT-061) Demonstrates Substantial Increase in FIX Activity in Non-human Primates ~ ~ Plans to Initiate Pivotal Study with Enhanced AMT-061 in 2018 ~ ~ Achieves Alignment with FDA on Streamlined Clinical and Regulatory Strategy for AMT-061, Which Will be Included Under Existing Breakthrough Therapy Designation ~ ~ Acquires a Patent Family ...

Fabric Genomics Partners to Improve Pediatric Care

Partnerships with Genomics England, Rady Children’s Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics’ algorithm-based genome analysis Fabric Genomics has partnered with

Gene therapy that reboots body’s immune cells to fight non-Hodgkin’s lymphoma approved by FDA

Monsanto, DowDupont execs discuss transformative impact of gene-editing and data science on farming

Viewpoint: Overly strict human gene-editing regulations lets patients suffer and die

Viewpoint: Overly strict human gene-editing regulations let patients suffer and die

One-fourth of cow genome descendant from snakes and lizards, study shows

Maria Calamaro Promoted to Executive Advisor, CMS Quality Payment Program at Healthcare Administrative Partners

Healthcare Administrative Partners (HAP), a comprehensive revenue cycle management solutions provider, is pleased to announce that Maria Calamaro has been promoted to Executive Advisor, CMS Quality Payment Program (QPP). Ms. Calamaro is an industry expert in CMS Quality and Compliance Programs including the Quality Payment Program’s Merit Based ...

Global and Asia Mesenchymal Stem Cells Market Status and Future Forecast 20132023 [Report Updated: 13102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Global DNA Microarray Market Analysis 20122017 and Forecast 20182023 [Report Updated: 11082017] Prices from USD $2980

SnapshotDNA microarray also many other names, including DNA chipgenome chipexpression chip and gene array. A DNA microarray consists of a predetermined assortment of nucleic acid probes attached to a surface. To assess gene expression, researchers derive complementary DNA cDNA from cellular RNA, label the cDNA with a fluorescent marker, wash labeled cDNA over the array, and use lasers to assess ho...

Tempus Unveils Tempus xT, 595 Gene Panel Aimed at Empowering Data-Driven Cancer Care

CHICAGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Tempus today announced the launch of its new comprehensive genomic sequencing panel, Tempus xT, which analyzes 595 genes relevant to the diagnosis, prognosis and therapeutic targeting of cancer. The panel will sequence a patient’s tumor DNA and RNA, as well as a matched normal blood or saliva to help ordering clinicians determine the targeted thera...

FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma

The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for...

Lysogene Announces Company Presentations at Upcoming Scientific Conferences

Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases, today announced that it will be participating in and presenting at several scientific events in the upcoming weeks. A detailed list of the October and November events is a...

Global DNA Microarray Market Analysis 20112017 and Forecast 20182023 [Report Updated: 22092017] Prices from USD $2980

SnapshotDNA microarray also many other names, including DNA chipgenome chipexpression chip and gene array.A DNA microarray consists of a predetermined assortment of nucleic acid probes attached to a surface. To assess gene expression, researchers derive complementary DNA cDNA from cellular RNA, label the cDNA with a fluorescent marker, wash labeled cDNA over the array, and use lasers to assess how...

Insitome Launches “Metabolism,” Offers Genetic Insights Into Important Diet and Nutrition-Related Genomic Traits

New genomics app reveals the evolutionary story behind our diets and proof that we are what we eat. AUSTIN, TX (PRWEB) October 18, 2017 Insitome, the company narrating the story you carry in your DNA, today launched their newest offering, the Metabolism Insight. The new app combines the most advanced DNA sequencing technologies with expert storytelling to help users uncover insights into eight im...

Ultra-personal therapy: Gene tumor boards guide cancer care

Gene tumor boards study a patient's cancer genes and match treatments to mutations that seem to drive the disease.

Genetic engineering and gene silencing could fight deadly crop mycotoxins—if not blocked by activists

Simon Chin, CEO of IRIS Wellness Labs and IRIS Biotechnologies, Spoke About DNA Testing at the Global Wellness Summit 2017 Where Wellness Moonshot Was Launched

Talk on DNA Testing at the Global Wellness Summit 2017. SANTA CLARA, Calif. (PRWEB) October 18, 2017 Simon Chin, CEO of IRIS Biotechnologies Inc. (OTC MKTS:IRSB), and its subsidiary, IRIS Wellness Labs, Inc. was one of five panelists to address the issue “Are DNA and Biomarker Tests Ready for Prime Time?” at the Global Wellness Summit in Palm Beach, Florida. Dr. Kenneth R. Pelletier, PhD, UCS...

10x Genomics Announces the Addition of Unbiased Gene Expression and B-cell Repertoire to the Chromium Single Cell V(D)J Solution

-- New products for profiling adaptive immunity will be presented at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) held in Orlando, FL – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, this week will launch new products for their Chromium™ Immune Repertoire Prof...

10x Genomics Enables High-Volume Studies by Providing More Affordable Solutions for Whole Genome and Exome Analysis

-- Customer data and updated pricing will be presented at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) held in Orlando, FL -- 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced more affordable pricing for their Chromium™Genome, Exome and de novo Asse...

'Luxturna' recommendation good for all AAV based gene therapies says advocacy group

The US approval recommendation for Spark Therapeuticsâ blindness gene therapy voretigene neparvovec is also an endorsement of AAV delivery technologies according to the Alliance for Regenerative Medicine.

Lilly, CureVac Ink $1.795B+ mRNA Cancer Vaccine Collaboration

Eli Lilly will partner to develop and commercialize up to five cancer vaccines based on CureVac's RNActive ® technology, the companies said today, through a collaboration that could generate up to $1.795 billion-plus for CureVac. The companies plan to use RNActive to deliver mRNA that directs the human immune system to target neoantigens across multiple tumor types. These neoantigens,...

Quick Search
Advertisement
 

review and buy Bioinformatics market research data and corporate reports here